BIIB068

CAT: 0804-HY-131342-01Size: 5 mgDry Ice: NoHazardous: No
CAT#:0804-HY-131342-01Size:5 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
BIIB068 is a potent, selective, reversible and orally active BTK inhibitor with an IC50 of 1 nM and a Kd of 0.3 nM. BIIB068 shows more >400-fold selective for BTK than other kinases. BIIB068 has the potential for autoimmune diseases research[1].
CAS Number
[1798787-27-5]
UNSPSC
12352005
Hazard Statement
H302, H315, H319
Target
Btk
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/biib068.html
Concentration
10mM
Purity
99.69
Solubility
DMSO : 31.25 mg/mL (ultrasonic)
Smiles
O=C(N1CC(OC(C)C)C1)NCC2=CC=C(C3=NC(NC4=CN(C)N=C4)=NC=C3)C=C2C
Molecular Formula
C23H29N7O2
Molecular Weight
435.52
Precautions
H302, H315, H319
References & Citations
[1]Bin Ma, Tonika Bohnert, et al. Discovery of BIIB068: A Selective, Potent, Reversible Bruton's Tyrosine Kinase Inhibitor as an Orally Efficacious Agent for Autoimmune Diseases. J Med Chem. 2020 Jul 22.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 1

Related Products

CatalogName
HY-P991376BIIB076
HY-P991433BIIB036
HY-139984-01BIIB091
HY-103537ABIIB042
HY-P991253BIIB022
HY-P991439BIIB023
HY-10212-01BIIB021
HY-103537(Rac) -BIIB042
HY-10212R-01BIIB021 (Standard)
HY-10212ABIIB021 (mesylate)

Alternative Products

CatalogName
BA8834-5.1BIIB068

Popular Products